Literature DB >> 22322496

Criteria for the prescription of oral bisphosphonates for the treatment of osteoporosis in a series of women referred for tooth extraction.

Márcio Diniz-Freitas1, Javier Fernández-Feijoo, Paula Fernández-Montenegro, Antonio González-Mosquera, Emma Vázquez-García, Pedro Diz-Dios.   

Abstract

OBJECTIVE: To evaluate the criteria for the prescription of oral bisphosphonates (OB) in a series of women with osteoporosis referred for tooth extraction. STUDY
DESIGN: The study included 38 postmenopausal women on treatment with OBs. The following variables were analysed: age, weight, height, type of OB and duration of treatment, bone densitometry and risk factors for osteoporosis. In addition, the osteoporosis self-assessment tool (OST) was administered and collagen type I C-telopeptide (CTX) levels were measured.
RESULTS: Bone densitometry had only been performed in six patients (15.7%) before starting OB treatment. Based on the results of the OST, nine (23.6%) of the participants presented a low risk of osteoporosis. CTX levels were measured in 23 patients: 11 (47.8%) presented values below 150 pg/ml.
CONCLUSION: Although all patients in the present series were on treatment with OBs, a large percentage did not satisfy the criteria for the initiation of treatment for postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322496      PMCID: PMC3476022          DOI: 10.4317/medoral.17681

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  15 in total

1.  [Postmenopausal osteoporosis. Clinical practice guide].

Authors: 
Journal:  Rev Clin Esp       Date:  2003-10       Impact factor: 1.556

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

Review 3.  Drug insight: Bisphosphonates for postmenopausal osteoporosis.

Authors:  Roland D Chapurlat; Pierre D Delmas
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-04

Review 4.  Preventing osteoporosis-related fractures: an overview.

Authors:  Margery Gass; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

Review 5.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

Review 6.  Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.

Authors:  Sven Otto; Mario Hakim Abu-Id; Stefano Fedele; Patrick H Warnke; Stephan T Becker; Andreas Kolk; Thomas Mücke; Gerson Mast; Robert Köhnke; Elias Volkmer; Florian Haasters; Olivier Lieger; Tateyuki Iizuka; Stephen Porter; Giuseppina Campisi; Giuseppe Colella; Oliver Ploder; Andreas Neff; Jörg Wiltfang; Michael Ehrenfeld; Thomas Kreusch; Klaus-Dietrich Wolff; Stephen R Stürzenbaum; Matthias Schieker; Christoph Pautke
Journal:  J Craniomaxillofac Surg       Date:  2010-07-02       Impact factor: 2.078

7.  Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Authors:  Robert E Marx; Joseph E Cillo; Juan J Ulloa
Journal:  J Oral Maxillofac Surg       Date:  2007-12       Impact factor: 1.895

8.  Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Authors:  N Yarom; R Yahalom; Y Shoshani; W Hamed; E Regev; S Elad
Journal:  Osteoporos Int       Date:  2007-06-28       Impact factor: 4.507

Review 9.  Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw.

Authors:  Sanford Baim; Paul D Miller
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more
  2 in total

Review 1.  Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review.

Authors:  Márcio Diniz-Freitas; Jacobo Limeres
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-03-01

Review 2.  Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link?

Authors:  Ignacio-Osoitz Leizaola-Cardesa; Antonio Aguilar-Salvatierra; Maximino Gonzalez-Jaranay; Gerardo Moreu; María-José Sala-Romero; Gerardo Gómez-Moreno
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.